TNF Pharmaceuticals (TNFA) Stock Price, News, Quotes-Moomoo

Account Info

Log Out

US Stock MarketDetailed Quotes

TNFA TNF Pharmaceuticals

Watchlist

1.360
+0.130+10.57%

Close Nov 21 16:00 ET

3.75MMarket Cap-100P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

TNF Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
SECNov 14 17:08 ET · Announcements
Eagle EGRX Delist; TNF Pharmaceuticals TNFA Equity Investment
BioPharmCatalystOct 2 14:01 ET
Express News | Tnf Pharmaceuticals Inc - Fully Funded for Clinical Trials for Next Two Years
ReutersOct 2 09:10 ET
TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market
BusinesswireOct 2 09:10 ET
Express News | Tnf Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market
ReutersOct 2 09:10 ET
Top Premarket Decliners
MT NewswiresSep 26 08:04 ET

Comments

Trytosaveabit

Oct 2 08:11

Update

$TNF Pharmaceuticals (TNFA.US)$ TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market
1 MINUTE AGO, 9:10 AM EDT
VIA BUSINESSWIRE
Prevail Partners, LLC investment priced at more than a 40% premium to market
Prevail InfoWorks, Inc. to act as Clinical Research Organization partner; global full service CRO with hundreds of clinical trials over a decade
TNF Pharmaceuticals fully funded for clinical trials for next two years